Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Pretzsch, CM; Floris, DL; Voinescu, B; Elsahib, M; Mendez, MA; Wichers, R; Ajram, L; Ivin, G; Heasman, M; Pretzsch, E; Williams, S; Murphy, DGM; Daly, E; McAlonan, GM.

Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin

Molecular Autism. 2021; 12(1): 49-49 Nº de citas: 20 [doi:10.1186/s13229-021-00454-6]

Siafis, S; Rodolico, A; Ciray, O; Murphy, DG; Parellada, M; Arango, C; Leucht, S.

Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder

Brain Sciences. 2021; 11(7): Nº de citas: 4 [doi:10.3390/brainsci11070908]

Jongsma, HE; Gayer-Anderson, C; Tarricone, I; Velthorst, E; van der Ven, E; Quattrone, D; di Forti, M; Menezes, PR; Del-Ben, CM; Arango, C; Lasalvia, A; Berardi, D; La Cascia, C; Bobes, J; Bernardo, M; Sanjuaan, J; Santos, JL; Arrojo, M; de Haan, L; Tortelli, A; Szoke, A; Murray, RM; Rutten, BP; van Os, J; Morgan, C; Jones, PB; Kirkbride, JB; EU-GEI WP2 Grp.

Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study

PSYCHOLOGICAL MEDICINE. 2021; 51(9): 1536-1548 Nº de citas: 79 [doi:10.1017/S003329172000029X]

Bernardo, M; Amoretti, S; Cuesta, MJ; Parellada, M; Mezquida, G; 2EPs Grp.

The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design

REVISTA DE PSIQUIATRIA Y SALUD MENTAL. 2021; 14(3): 164-176 Nº de citas: 14 [doi:10.1016/j.rpsm.2020.07.004]

Kuzman, MR; Vahip, S; Fiorillo, A; Beezhold, J; da Costa, MP; Skugarevsky, O; Dom, G; Pajevic, I; Peles, AM; Mohr, P; Kleinberg, A; Chkonia, E; Balazs, J; Flannery, W; Mazaliauskiene, R; Chihai, J; Samochowiec, J; Cozman, D; Mihajlovic, G; Izakova, L; Arango, C; Goorwod, P.

Mental health services during the first wave of the COVID-19 pandemic in Europe: Results from the EPA Ambassadors Survey and implications for clinical practice

EUROPEAN PSYCHIATRY. 2021; 64(1): Nº de citas: 44 [doi:10.1192/j.eurpsy.2021.2215]

Fusar-Poli, P; Correll, CU; Arango, C; Berk, M; Patel, V; Ioannidis, JPA.

Preventive psychiatry: a blueprint for improving the mental health of young people

World Psychiatry. 2021; 20(2): 200-221 Nº de citas: 358 [doi:10.1002/wps.20869]

Molina-Garcia, M; Fraguas, D; del Rey-Mejias, A; Mezquida, G; Sanchez-Torres, AM; Amoretti, S; Lobo, A; Gonzalez-Pinto, A; Andreu-Bernabeu, A; Corripio, I; Vieta, E; Baeza, I; Mane, A; Cuesta, M; de la Serna, E; Paya, B; Zorrilla, I; Arango, C; Bernardo, M; Rapado-Castro, M; Parellada, M; PEPs Grp.

The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis

Journal of Clinical Medicine. 2021; 10(11): Nº de citas: 11 [doi:10.3390/jcm10112474]

Quattrone, D; Ferraro, L; Tripoli, G; La Cascia, C; Quigley, H; Quattrone, A; Jongsma, HE; Del Peschio, S; Gatto, G; Gayer-Anderson, C; Jones, PB; Kirkbride, JB; La Barbera, D; Tarricone, I; Berardi, D; Tosato, S; Lasalvia, A; Szoke, A; Arango, C; Bernardo, M; Bobes, J; Del Ben, CM; Menezes, PR; Llorca, PM; Santos, JL; Sanjuan, J; Tortelli, A; Velthorst, E; de Haan, L; Rutten, BPF; Lynskey, MT; Freeman, TP; Sham, PC; Cardno, AG; Vassos, E; van Os, J; Morgan, C; Reininghaus, U; Lewis, CM; Murray, RM; Di Forti, M; EU-GEI grp.

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study

PSYCHOLOGICAL MEDICINE. 2021; 51(8): 1329-1337 Nº de citas: 60 [doi:10.1017/S0033291720000082]

Amoretti, S; Mezquida, G; Rosa, AR; Bioque, M; Cuesta, MJ; Pina-Camacho, L; Garcia-Rizo, C; Barcones, F; Gonzalez-Pinto, A; Merchan-Naranjo, J; Corripio, I; Vieta, E; Baeza, I; Cortizo, R; Bonnin, CM; Torrent, C; Bernardo, M; PEPs Grp.

The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 47: 98-111 Nº de citas: 27 [doi:10.1016/j.euroneuro.2021.02.007]

Amoretti, S; Verdolini, N; Mezquida, G; Rabelo-da-Ponte, FD; Cuesta, MJ; Pina-Camacho, L; Gomez-Ramiro, M; De-la-Camara, C; Gonzalez-Pinto, A; Diaz-Caneja, CM; Corripio, I; Vieta, E; de la Serna, E; Mane, A; Sole, B; Carvalho, AF; Serra, M; Bernardo, M.

Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 47: 112-129 Nº de citas: 18 [doi:10.1016/j.euroneuro.2021.01.095]

de Pablo, GS; Besana, F; Arienti, V; Catalan, A; Vaquerizo-Serrano, J; Cabras, A; Pereira, J; Soardo, L; Coronelli, F; Kaur, S; da Silva, J; Oliver, D; Petros, N; Moreno, C; Gonzalez-Pinto, A; Diaz-Caneja, CM; Shin, JI; Politi, P; Solmi, M; Borgatti, R; Mensi, MM; Arango, C; Correll, CU; McGuire, P; Fusar-Poli, P.

Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis

EClinicalMedicine. 2021; 36: 100909-100909 Nº de citas: 51 [doi:10.1016/j.eclinm.2021.100909]

Sugranyes, G; de la Serna, E; Ilzarbe, D; Pariente, JC; Borras, R; Romero, S; Rosa, M; Baeza, I; Moreno, MD; Bernardo, M; Vieta, E; Castro-Fornieles, J.

Brain structural trajectories in youth at familial risk for schizophrenia or bipolar disorder according to development of psychosis spectrum symptoms

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY. 2021; 62(6): 780-789 Nº de citas: 18 [doi:10.1111/jcpp.13321]

Hernandez-Huerta, D; Parro-Torres, C; Madoz-Gurpide, A; Perez-Elias, MJ; Moreno-Guillen, S; Ochoa-Mangado, E.

Personality and adherence to antiretroviral therapy in HIV-infected adult patients

JOURNAL OF PSYCHOSOMATIC RESEARCH. 2021; 144: 110413-110413 Nº de citas: 6 [doi:10.1016/j.jpsychores.2021.110413]

de Pablo, GS; De Micheli, A; Solmi, M; Oliver, D; Catalan, A; Verdino, V; Di Maggio, L; Bonoldi, I; Radua, J; Boy, OB; Provenzani, U; Ruzzi, F; Calorio, F; Nosari, G; Di Marco, B; Famularo, I; Montealegre, I; Signorini, L; Molteni, S; Filosi, E; Mensi, M; Balottin, U; Politi, P; Shin, JI; Correll, CU; Arango, C; Fusar-Poli, P.

Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis

HARVARD REVIEW OF PSYCHIATRY. 2021; 29(3): 196-215 Nº de citas: 41 [doi:10.1097/HRP.0000000000000294]

Pina-Camacho, L; Vidal, J; Picouto, MD; Ortiz, EJ; Jaaskelainen, FDM; Moreno, C; Arango, C; Hernandez-Sampelayo, T; Parellada, M; Grupo Conflpadres.

Patient care, right to information and consent for minors in situations of parental conflict. Clinical guidelines in the context of Spanish legislation

ANALES DE PEDIATRIA. 2021; 94(5): Nº de citas: 2 [doi:10.1016/j.anpedi.2020.09.007]

Casquero-Veiga, M; Romero-Miguel, D; MacDowell, KS; Torres-Sanchez, S; Garcia-Partida, JA; Lamanna-Rama, N; Gomez-Rangel, V; Romero-Miranda, A; Berrocoso, E; Leza, JC; Arango, C; Desco, M; Soto-Montenegro, ML.

Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 46: 14-27 Nº de citas: 18 [doi:10.1016/j.euroneuro.2021.02.001]

Izquierdo, A; Cabello, M; Leal, I; Ayora, M; Rodriguez-Jimenez, R; Ibanez, A; Diaz-Marsa, M; Bravo-Ortiz, MF; Baca-Garcia, E; Madrigal, JLM; Fares-Otero, NE; Diaz-Caneja, CM; Arango, C; Mateos, JLA; AGES-CM grp.

How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach

HEALTH & PLACE. 2021; 69: 102555-102555 Nº de citas: 4 [doi:10.1016/j.healthplace.2021.102555]

Fraguas, D; Diaz-Caneja, CM; Pina-Camacho, L; van Rossum, IW; Baandrup, L; Sommer, IE; Glenthoj, B; Kahn, RS; Leucht, S; Arango, C.

The role of depression in the prediction of a "late" remission in first-episode psychosis: An analysis of the OPTiMiSE study

SCHIZOPHRENIA RESEARCH. 2021; 231: 100-107 Nº de citas: 9 [doi:10.1016/j.schres.2021.03.010]